Preventing Newborn Infection with Maternal Immunization

Preventing newborn infection with maternal immunization.

Group B streptococcal disease is a common cause of bacterial sepsis in newborns and is often fatal. To protect these babies, a vaccination program must target pregnant women for immunization so that the resulting antibodies can be passively delivered from the mother to the fetus. Scientists met in Siena, Italy, to discuss potential approaches to maternal immunization for the prevention of perin...

Preventing congenital varicella syndrome with immunization.

complication of infection with maternal varicella before 20 weeks of pregnancy. Prospective studies in Europe and North America have shown that the incidence of congenital varicella syndrome in maternal varicella contracted in the first 20 weeks of pregnancy is about 1%–2%. Based on this estimated risk (1%), on an estimated risk of varicella infection during pregnancy of two maternal infections...

Domestic maternal experience with preterm newborn children.

OBJECTIVE Exploring maternal experience with premature newborn children in a domestic environment. METHODS The study was qualitative and used focus group interviews with 24 women who had had preterm deliveries in a public maternity hospital located in Northeast Brazil during June and October 2005. The mothers returned to the hospital facility at least 30 days after the newborn were discharged...

Immunization with Recombinant Sip Protein Infection in Neonatal Mice by Maternal Protection from Group B Streptococcal

Antibiotic Prophylaxis and Preventing Postpartum Infection

بحث بر روی کاربرد پروفیلاکسی آنتی بیوتیک ها در مامائی، در اواخر سال ۱۹۴۰ شروع شد و تجویز پروفیلاکسی پنی سیلین به تمام بیماران در لیبر باعث کاهش شیوع تب از ۶/۳ به ۴/۲٪ می شود. ولی هرگز آنتی بیوتیک پروفیلاکسی بطور عمومی مورد قبول واقع نشد. بدلیل اینکه اولا شیوع عمومی عفونت، پائین است و عفونتها بندرت شدید می شوند، بطوریکه بیش از ۹۵ تا ۹۷ بیماران احتیاج به آنتی بیوتیک پیدا نمی کنند. شاید، تجویز غیر...